The amount of the funding was not disclosed.
The company intends to use the funds to expand into additional markets.
Led by Lucienne Ide, CEO, Rimidi provides a digital health solution for physicians and patients to better manage chronic diseases. The company’s flagship product, Diabetes+Me™, provides a cloud-based platform for diabetes management and allows patients to track their health and lifestyle data, as well as obtain medical and nutritional information about their condition.
The care team can leverage the data through proprietary analytics for better decision making for treatment options, population management and improved care.
Rimidi had received funding from SOURCE, a partnership between the Hitachi Foundation, Investor’s Circle and Village Capital, as well as the JumpFund.